ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,073,675 | -24.7% | 152,230 | +0.4% | 0.01% | -25.0% |
| Q2 2023 | $5,407,019 | +50.5% | 151,627 | +7.2% | 0.02% | +45.5% |
| Q1 2023 | $3,591,789 | -39.8% | 141,409 | -3.9% | 0.01% | -45.0% |
| Q4 2022 | $5,966,457 | +133.3% | 147,102 | +91.5% | 0.02% | +122.2% |
| Q3 2022 | $2,557,000 | +4.1% | 76,820 | +8.1% | 0.01% | 0.0% |
| Q2 2022 | $2,457,000 | -61.6% | 71,090 | -48.9% | 0.01% | -50.0% |
| Q1 2022 | $6,398,000 | -25.9% | 139,107 | +6.8% | 0.02% | -5.3% |
| Q4 2021 | $8,632,000 | +15.9% | 130,196 | +9.1% | 0.02% | +11.8% |
| Q3 2021 | $7,450,000 | +2.9% | 119,341 | +36.5% | 0.02% | -5.6% |
| Q2 2021 | $7,241,000 | +29.9% | 87,432 | +4.0% | 0.02% | +20.0% |
| Q1 2021 | $5,573,000 | -52.2% | 84,049 | -44.7% | 0.02% | -53.1% |
| Q4 2020 | $11,655,000 | +78.7% | 151,895 | +0.3% | 0.03% | +39.1% |
| Q3 2020 | $6,521,000 | +2.4% | 151,434 | +2.7% | 0.02% | -4.2% |
| Q2 2020 | $6,370,000 | +103.8% | 147,496 | +35.8% | 0.02% | +41.2% |
| Q1 2020 | $3,125,000 | +45.3% | 108,633 | +220.4% | 0.02% | +41.7% |
| Q4 2019 | $2,151,000 | – | 33,910 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |